Chuang‐Wei Wang
Impact in
- Pharmacology top 0.5%
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Dermatology top 5%
- Dermatological and COVID-19 studies
- Chemotherapy-related skin toxicity
Papers in
- Pharmacology 54
- Drug-Induced Adverse Reactions 54
- Pharmacogenetics and Drug Metabolism 2
-
- Dermatological and COVID-19 studies 4
- Chemotherapy-related skin toxicity 2
- Co-authors
- Wen‐Hung Chung (39 shared papers)Chun‐Bing Chen (45 shared papers)Wen‐Hung Chung (36 shared papers)Ro‐Lan Dao (2 shared papers)Ya‐Ching Chang (13 shared papers)Shih‐Chi Su (7 shared papers)Rosaline Chung‐Yee Hui (16 shared papers)Wen‐Lang Fan (4 shared papers)
- Journals
- Journal of Investigative Dermatology (6 papers)Clinical Pharmacology & Therapeutics (4 papers)Allergy (3 papers)Clinical Immunology (3 papers)Journal of Allergy and Clinical Immunology (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chuang‐Wei Wang
75 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 89
- Pharmacology 1.5k
- Dermatology 119
- Pharmacology 129
- Immunology and Allergy 42
- Toxicology 41
Countries citing papers authored by Chuang‐Wei Wang
This map shows the geographic impact of Chuang‐Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuang‐Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuang‐Wei Wang more than expected).
Fields of papers citing papers by Chuang‐Wei Wang
This network shows the impact of papers produced by Chuang‐Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuang‐Wei Wang. The network helps show where Chuang‐Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chuang‐Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 228 | |
| 2 | 2016 | 158 | |
| 3 | 2016 | 129 | |
| 4 | 2018 | 129 | |
| 5 | 2017 | 110 | |
| 6 | 2019 | 97 | |
| 7 | 2016 | 82 | |
| 8 | 2018 | 70 | |
| 9 | 2018 | 65 | |
| 10 | 2020 | 65 | |
| 11 | 2018 | 64 | |
| 12 | 2019 | 61 | |
| 13 | 2013 | 60 | |
| 14 | 2022 | 49 | |
| 15 | 2022 | 46 | |
| 16 | 2017 | 44 | |
| 17 | 2001 | 42 | |
| 18 | 2021 | 42 | |
| 19 | 2019 | 39 | |
| 20 | 2006 | 34 |
About Chuang‐Wei Wang
Chuang‐Wei Wang is a scholar working on Pharmacology, Dermatology, Immunology, Oncology and Rheumatology, having authored 85 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (54 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Dermatological and COVID-19 studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-related skin toxicity (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pharmacology (1.5k citations), Dermatology (119 citations), Pharmacology (129 citations), Immunology and Allergy (42 citations) and Toxicology (41 citations). Chuang‐Wei Wang has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Hung Chung, Chun‐Bing Chen, Wen‐Hung Chung, Ro‐Lan Dao, Ya‐Ching Chang, Shih‐Chi Su, Rosaline Chung‐Yee Hui, Wen‐Lang Fan, Chun‐Wei Lu and Ren‐You Pan. Their work appears in journals such as Journal of Investigative Dermatology, Clinical Pharmacology & Therapeutics, Allergy, Clinical Immunology and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.